Original ArticleClinical Research: TherapeuticsA Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)
Clinical Research: Therapeutics
Under an Elsevier user license
open archive
Abbreviations
AVI
aortic vascular inflammation
CI
confidence interval
FDG-PET/CT
18F-2-fluorodeoxyglucose-positron emission tomography/computed tomography
HDL
high-density lipoprotein
LDL
low-density lipoprotein
PASI
psoriasis area and severity index
SD
standard deviation
SUV
standardized uptake value
TBR
target-to-background ratio
TNF
tumor necrosis fator
VLDL
very low-density lipoprotein
Cited by (0)
© 2019 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.